$CLIK

Click Holdings Ltd.

5
0
0

No SEC Form 4 filings for $CLIK in the last 30 days.

See all $CLIK insider activity →
High

Revenue rose 61.9% to $17.3 million, and all three businesses hit new revenue highs.

Click Holdings Limited (NASDAQ: CLIK) reported a 61.9% revenue increase to HK$135.2 million for FY2026, with all segments achieving record highs. Gross profit rose 68.9% to HK$21.6 million, and the company turned a net income of HK$14.59 million, reversing a prior-year loss. Management expects continued growth in nursing, logistics, and professional services.

Click Holdings Ltd. (CLIK): Financial results for FY2026

Click Holdings Ltd. (CLIK) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Click Holdings Limited (NASDAQ: CLIK) Reports Record Full-Year Results: Revenue, Gross Profit and Net Income Hit New Highs; Every Segment Delivers Record Revenue Nursing +63% to HK$56.8 million | Professional more than doubles to HK$36.0 million | Logistics +36% to H

FDA clears Motivista for negative symptoms in schizophrenia

Click Therapeutics' Motivista, a prescription digital therapeutic for negative symptoms of schizophrenia, received FDA 510(k) clearance. It is administered via smartphone as an adjunct to outpatient therapy. The company reported a 6.8-point improvement in negative symptom severity in a phase III study, compared to 4.2 in the control group. Motivista is not designed for acute symptoms or as a replacement for clinician-managed care.

CLIK sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 5 news stories mentioning CLIK (Click Holdings Ltd.). Coverage has skewed bullish: 5 bullish, 0 neutral, and 0 bearish.

Recent CLIK coverage spans financial news, insider activity and earnings.

What's driving CLIK

AlphAI scores every news story that mentions CLIK with an AI model for sentiment and relevance, and aggregates insider trades from Click Holdings Ltd.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $CLIK

Score
$CLIKHigh

Click Holdings Ltd. (CLIK): Financial results for FY2026

Click Holdings Ltd. (CLIK) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Click Holdings Limited (NASDAQ: CLIK) Reports Record Full-Year Results: Revenue, Gross Profit and Net Income Hit New Highs; Every Segment Delivers Record Revenue Nursing +63% to HK$56.8 million | Professional more than doubles to HK$36.0 million | Logistics +36% to H

$CLIKMedAI 8/10

FDA clears Motivista for negative symptoms in schizophrenia

Click Therapeutics' Motivista, a prescription digital therapeutic for negative symptoms of schizophrenia, received FDA 510(k) clearance. It is administered via smartphone as an adjunct to outpatient therapy. The company reported a 6.8-point improvement in negative symptom severity in a phase III study, compared to 4.2 in the control group. Motivista is not designed for acute symptoms or as a replacement for clinician-managed care.

Click Holdings Limited: Click Holdings Logistics Segment Surges Over 42% YoY in Q4; Record high HK$4.4 million in June; and 135,000+ Service Hours Drive Operating Leverage and Expansion Momentum

Click Holdings Limited (CLIK) reported Q4 2026 logistics revenue growth of 42% YoY and 20% QoQ, with June revenue hitting a record HK$4.4 million. The company attributed this to digital optimizations and enterprise client onboarding, driving margin expansion and record service hours.

$CLIKMedAI 8/10

CLIK CEO Purchases Shares Following Announcement of Strong Revenue Growth of 73% in Q3 FY2025

Click Holdings (NASDAQ: CLIK) said its CEO, Chan Chun Sing, bought shares in the open market over three consecutive trading days ending June 8, 2026, totaling 52,000 Class A ordinary shares for about US$96,800, according to the company’s Form 4 filed with the SEC. The purchases followed disclosure of ~73% year-over-year revenue growth in Q3 FY2025/26 and a shareholder meeting notice to approve a potential share consolidation to help maintain Nasdaq listing.

Related tickers